A recent study reveals that individuals who stop using new slimming jabs like Mounjaro or Wegovy tend to recover reduced body mass at a significantly accelerated pace than those who end traditional lifestyle regimens.
Research printed in a prominent health publication shows that while overweight individuals can lose about a fifth of their body weight while undergoing treatment, the mass returns at an estimated rate of nearly a kilo each month upon discontinuation.
"Users purchasing such drugs need to be cognizant of the danger of rapid rebound weight gain when the treatment is stopped," cautioned researcher Dr. Susan Jebb.
This pace of regain means a reversion to starting mass within about one and a half years.
Weighing Treatments
The analysis, which reviewed dozens of studies involving thousands of patients, compared the outcomes of GLP-1 agonists with older methods.
Researchers note that people who shed pounds through dieting usually see a slower creep back—around 100 grams monthly—post-intervention.
The Reason for the Fast Regain
Experts propose the mode of action of the drugs explains the amplified weight return.
These medications mimic a body's own chemical called GLP-1, which helps regulate hunger.
"Long-term administration of GLP-1 concentrations far above than normal could lead to the system to generate a reduced amount of its own natural hormone, and could diminish responsiveness to its effects," noted Dr. Adam Collins, a dietetics expert.
"Stopping of this hormone supplement leads to appetite is no longer kept in check, making binge eating a significant risk."
A Chronic Condition?
Medical guidelines advise the injections for individuals with obesity-related health risks, accompanied by recommended diet and exercise modifications.
Many experts say that, due to the high risk of relapse, the therapy might need to be long-term.
This perspective is echoed by drug manufacturers, who say that the findings "underscore the long-term character of obesity," comparing it to managing diseases like hypertension.
User Experiences
People who have discontinued the medication describe a sudden resurgence of appetite.
"It was like a trigger flipping and you become starving," recalled a patient.
This difficulty is compounded if users have not developed permanent lifestyle or habit modifications during therapy.
Growing Adoption
Figures suggest that a significant number of people in the UK have tried weight-loss jabs in the past year, with demand being substantial.
- Adoption is higher among females compared to men.
- The middle-aged age group shows the greatest usage rates.
- Many access the drugs through private healthcare rather than the NHS.
In conclusion, clinicians caution that while GLP-1 drugs are effective tools for shedding pounds, they are not a permanent fix and lasting health benefits hinges on integrated lifestyle changes.
